scholarly journals B-Cell Lymphoblastic Lymphoma in Relapse Presenting as a Uterine Mass: A Case Report and Review of Literature

2021 ◽  
pp. 868-873
Author(s):  
Rim Abou Chakra ◽  
Bernard Najib ◽  
Wael Abdallah ◽  
Mira Akiki ◽  
Lea El Khoury ◽  
...  
Keyword(s):  
Computed Tomography ◽  
B Cell ◽  
Lymphoblastic Leukemia ◽  
Lymph Node Involvement ◽  
Lymphoblastic Lymphoma ◽  
Review Of Literature ◽  
Positron Emission ◽  
Node Involvement ◽  
Endometrial Sarcoma ◽  
A Site

B-cell lymphoblastic lymphoma (LBL) is a highly aggressive malignant proliferation of lymphoblasts of B-origin grouped with acute lymphoblastic leukemia. Multiple studies demonstrated the various sites of involvement in adult LBL. The involvement of the uterus as a site of relapse for such disease is rare. We herein report the case of relapsed B-cell LBL mimicking endometrial sarcoma. The patient is a 56-year-old female patient known to have B-cell LBL on chemotherapy. She presented with abdominal pain and fever. Positron emission tomodensitometry-computed tomography showed the presence of a uterine mass with bilateral iliac lymph node involvement. She underwent surgery with mass removal and pathology showed relapsed B-cell LBL.

Modern Staging and Utility of PET Imaging in Esophageal Cancer Management

2008 ◽  
Vol 6 (9) ◽  
pp. 862-869 ◽  
Author(s):  
Kwang-Yu Chang ◽  
Jang-Yang Chang ◽  
Joseph Chao ◽  
Yun Yen
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Therapy ◽  
Imaging System ◽  
False Negative ◽  
Lymph Node Involvement ◽  
Cancer Management ◽  
Positron Emission ◽  
Node Involvement ◽  
Positive Results ◽  
Locoregional Lymph Node

Esophageal cancer is the eighth most common cancer worldwide, and one of the most fatal diseases despite modern medical treatment. Because correct staging and surveillance of neoadjuvant therapy for esophageal cancer is mandatory for further treatment planning, choosing a modern imaging system is important. The development of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) has provided alternate means of tumor detection distinct from more conventional methods. This modality has extraordinary performance in detecting locoregional lymph node involvement and distant metastatic disease, and has been introduced as a powerful tool in many guidelines. However, some factors still lead to false-negative or -positive results, raising questions of its accuracy. This article discusses the clinical efficacy of PET in staging and surveillance of neoadjuvant therapy in esophageal cancer, comparing its accuracy with conventional imaging modalities.

Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy

2015 ◽  
Vol 49 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Stephen S. Connolly ◽  
Aditya Raja ◽  
Helen Stunell ◽  
Deepak Parashar ◽  
Sara Upponi ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lymph Node ◽  
Diagnostic Accuracy ◽  
Radical Nephrectomy ◽  
Lymph Node Involvement ◽  
Node Involvement
Sign in / Sign up

Export Citation Format

Share Document